Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Albuked (Kedrion Biopharma, Grifols) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

globenewswire.com
GRFS Grifols S.A. is mentioned as a key player in the Albuked market, having completed a phase 3 clinical study for its Albutein therapy, which shows potential in extending survival for liver transplant patients. This indicates ongoing development and potential market impact.

Albuked (Kedrion Biopharma, Grifols) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F Dublin, March 10, 2026 (GLOBE NEWSWIRE) -- The "Albuked Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering.

The Albuked market has witnessed growth, driven by clinical applications in shock management, reliance on plasma-derived albumin, and the increased incidence of liver disorders. The hospital-based critical care segment has also expanded, and the established efficacy of albumin in fluid management has contributed to this growth. Moving forward, the market will benefit from the heightened demand for safer non-plasma products, a rise in burn and trauma cases, expanded recombinant protein manufacturing, increased ICU admissions, and regulatory support for synthetic proteins.

Liver disorders are significant drivers of the Albuked market. Conditions such as hepatitis, cirrhosis, and fatty liver disease impact liver function. Factors contributing to these conditions include excessive alcohol intake, obesity, viral infections, and genetic components. Albuked is vital in managing acute liver failure by maintaining plasma colloid osmotic pressure and binding excess bilirubin. According to the American Liver Foundation, over 100 million individuals in the U.S. suffer from liver disease, with many cases undiagnosed. The Journal of Hepatology reports that liver disease causes over 2 million deaths annually worldwide.

Advanced human albumin injection therapies are transforming the market by managing conditions like hypoalbuminemia and liver cirrhosis. Grifols S.A., completing a phase 3 clinical study in July 2023, has advanced Albutein therapy, potentially extending survival in patients awaiting liver transplantation. Kedrion Biopharma's partnership with Bio Products Laboratory aims to expand plasma-derived therapies in China, enhancing access to these crucial treatments.

Key players in the Albuked market include Kedrion Biopharma Inc. and Grifols S.A. North America leads the market, with Asia-Pacific expected to grow rapidly. The regions covered include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. Countries detailed in market studies are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, and Canada.

Tariffs have influenced the market by raising costs for bioprocessing equipment and recombinant raw materials, particularly in Asia-Pacific and Europe, impacting the production costs of synthetic albumin formulations. However, these tariffs have spurred local biomanufacturing investments and domestic recombinant albumin production.

The Albuked market report offers insights into market statistics, including market size, regional shares, competitors, detailed segments, trends, and opportunities. Albuked is a synthetic human albumin-based protein, treating hypoalbuminemia and supporting conditions like liver cirrhosis, nephrotic syndrome, and burns. Available formulations include Albuked 5% and Albuked 25%, distributed through hospitals, clinics, and pharmacies. The market encompasses sales of Albuminar-5, Albuminar-25, and Buminate, defined by revenues from goods and services in the specified geography, focusing on creation values rather than resale.

Key Topics Covered:

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Albuked Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Albuked Market Attractiveness Scoring and Analysis

3. Albuked Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List of Key Raw Materials, Resources & Suppliers

3.3. List of Major Distributors and Channel Partners

3.4. List of Major End Users

4. Global Albuked Market Trends and Strategies

4.1. Key Technologies & Future Trends

4.2. Major Trends

5. Albuked Market Analysis of End Use Industries

5.1. Hospitals

5.2. Critical Care Centers

5.3. Burn Treatment Centers

5.4. Specialty Clinics

5.5. Emergency Care Units

6. Albuked Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, and Covid and Recovery on the Market

7. Global Albuked Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis

7.1. Global Albuked PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Albuked Market Size, Comparisons and Growth Rate Analysis

7.3. Global Albuked Historic Market Size and Growth, 2020-2025, Value ($ Billion)

7.4. Global Albuked Forecast Market Size and Growth, 2025-2030, 2035F, Value ($ Billion)

8. Global Albuked Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Albuked Market Segmentation

9.1. Global Albuked Market, Segmentation by Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

9.2. Global Albuked Market, Segmentation by Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

9.3. Global Albuked Market, Segmentation by Packaging Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

9.4. Global Albuked Market, Segmentation by Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

9.5. Global Albuked Market, Segmentation by End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10. Albuked Market Regional and Country Analysis

10.1. Global Albuked Market, Split by Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Albuked Market, Split by Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

For more information about this report visit https://www.researchandmarkets.com/r/g8q8gd

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.